Find Out if You Qualify for a Financial Reward by filling out the form below.
Investigation Details
On April 4, 2024, Dayforce was the subject of a report published by Blue Orca Capital. The report alleges that the Company “engages in highly aggressive revenue recognition and accounting maneuvers to inappropriately pull forward revenues and inflate profits.” The report continues, “Dayforce is plagued by worst-in-class GAAP gross margins, yet its stock trades at an unjustified 25%+ premium above other human capital management companies, likely because of a latticework of misperceptions created around the Company’s business and true profitability.” The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Ticker Symbol | Company Name | Join Deadline | Join |
---|---|---|---|
SUI | Sun Communities, Inc. | February 10, 2025 | Join |
SAVA | Cassava Sciences, Inc. | February 10, 2025 | Join |
APLT | Applied Therapeutics, Inc. | February 18, 2025 | Join |
BIOA | BioAge Labs, Inc. | March 10, 2025 | Join |
PCRX | Pacira BioSciences, Inc. | March 14, 2025 | Join |
NVO | Novo Nordisk A/S | March 25, 2025 | Join |
GO | Grocery Outlet Holding Corp. | March 31, 2025 | Join |
NEM | Newmont Corporation | April 01, 2025 | Join |